Cargando…
Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing
We have designed bispecific antibodies that bind one target (anti-Her3) in a bivalent IgG-like manner and contain one additional binding entity (anti-cMet) composed of one V(H) and one V(L) domain connected by a disulfide bond. The molecules are assembled by fusing a V(H,Cys44) domain via flexible c...
Autores principales: | Metz, Silke, Panke, Christian, Haas, Alexander K., Schanzer, Jürgen, Lau, Wilma, Croasdale, Rebecca, Hoffmann, Eike, Schneider, Britta, Auer, Johannes, Gassner, Christian, Bossenmaier, Birgit, Umana, Pablo, Sustmann, Claudio, Brinkmann, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449404/ https://www.ncbi.nlm.nih.gov/pubmed/22976197 http://dx.doi.org/10.1093/protein/gzs064 |
Ejemplares similares
-
TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations
por: Castoldi, Raffaella, et al.
Publicado: (2016) -
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
por: Schneider, Britta, et al.
Publicado: (2012) -
Quantification of cell surface proteins with bispecific antibodies
por: Panke, C., et al.
Publicado: (2013) -
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
por: Schanzer, Juergen M., et al.
Publicado: (2016) -
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity
por: Sustmann, Claudio, et al.
Publicado: (2019)